Nitric oxide and vascular insulin resistance

@article{Wu2009NitricOA,
  title={Nitric oxide and vascular insulin resistance},
  author={G. Wu and C. Meininger},
  journal={BioFactors},
  year={2009},
  volume={35}
}
  • G. Wu, C. Meininger
  • Published 2009
  • Biology, Medicine
  • BioFactors
  • Obesity and type‐II diabetes are growing major health issues worldwide. They are the leading risk factors for vascular insulin resistance, which plays an important role in the pathogenesis of cardiovascular disease, the leading cause of death in developed nations. Recent studies have shown that reduced synthesis of nitric oxide (NO; a major vasodilator) from L‐arginine in endothelial cells is a major factor contributing to the impaired action of insulin in the vasculature of obese and diabetic… CONTINUE READING
    117 Citations

    Paper Mentions

    l-Leucine and NO-mediated cardiovascular function
    • 24
    Uric acid induces endothelial dysfunction by vascular insulin resistance associated with the impairment of nitric oxide synthesis
    • 103
    Nitric oxide and energy metabolism in mammals
    • 90
    Anti-obesity and anti-diabetic effects of nitrate and nitrite.
    • 27
    Renal endothelial dysfunction in diabetic nephropathy.
    • H. Cheng, R. Harris
    • Biology, Medicine
    • Cardiovascular & hematological disorders drug targets
    • 2014
    • 66
    Regulation of nitric oxide production in health and disease
    • 205
    A Mitochondrial Approach to Cardiovascular Risk and Disease.
    • 4

    References

    SHOWING 1-10 OF 52 REFERENCES
    Arginine nutrition and cardiovascular function.
    • 251
    • PDF
    Cardiovascular actions of insulin.
    • 668
    • PDF
    Vascular function, insulin resistance and fatty acids
    • 313
    • PDF
    Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates.
    • 532
    • PDF
    Regulation of nitric oxide synthesis by dietary factors.
    • 250
    Tetrahydrobiopterin increases insulin sensitivity in patients with type 2 diabetes and coronary heart disease.
    • 49
    • PDF